Cargando…
Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135376/ https://www.ncbi.nlm.nih.gov/pubmed/37107047 http://dx.doi.org/10.3390/antibiotics12040685 |
_version_ | 1785031963699052544 |
---|---|
author | Altmann, Dominique Waibel, Felix W. A. Forgo, Gabor Grigorean, Alexandru Lipsky, Benjamin A. Uçkay, Ilker Schöni, Madlaina |
author_facet | Altmann, Dominique Waibel, Felix W. A. Forgo, Gabor Grigorean, Alexandru Lipsky, Benjamin A. Uçkay, Ilker Schöni, Madlaina |
author_sort | Altmann, Dominique |
collection | PubMed |
description | For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing the perioperative period of 2 weeks before and after surgery), and the influence of administering parenteral antibiotic therapy on the outcomes of DFIs. Among 838 ischemic DFIs with moderate-to-severe symptomatic peripheral arterial disease, we revascularized 608 (72%; 562 angioplasties, 62 vascular surgeries) and surgically debrided all. The median length of postsurgical antibiotic therapy was 21 days (given parenterally for the initial 7 days). The median time delay between revascularization and debridement surgery was 7 days. During the long-term follow-up, treatment failed and required reoperation in 182 DFI episodes (30%). By multivariate Cox regression analyses, neither a delay between surgery and angioplasty (hazard ratio 1.0, 95% confidence interval 1.0–1.0), nor the postsurgical sequence of angioplasty (HR 0.9, 95% CI 0.5–1.8), nor long-duration parenteral antibiotic therapy (HR 1.0, 95% CI 0.9–1.1) prevented failures. Our results might indicate the feasibility of a more practical approach to ischemic DFIs in terms of timing of vascularization and more oral antibiotic use. |
format | Online Article Text |
id | pubmed-10135376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101353762023-04-28 Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections Altmann, Dominique Waibel, Felix W. A. Forgo, Gabor Grigorean, Alexandru Lipsky, Benjamin A. Uçkay, Ilker Schöni, Madlaina Antibiotics (Basel) Article For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing the perioperative period of 2 weeks before and after surgery), and the influence of administering parenteral antibiotic therapy on the outcomes of DFIs. Among 838 ischemic DFIs with moderate-to-severe symptomatic peripheral arterial disease, we revascularized 608 (72%; 562 angioplasties, 62 vascular surgeries) and surgically debrided all. The median length of postsurgical antibiotic therapy was 21 days (given parenterally for the initial 7 days). The median time delay between revascularization and debridement surgery was 7 days. During the long-term follow-up, treatment failed and required reoperation in 182 DFI episodes (30%). By multivariate Cox regression analyses, neither a delay between surgery and angioplasty (hazard ratio 1.0, 95% confidence interval 1.0–1.0), nor the postsurgical sequence of angioplasty (HR 0.9, 95% CI 0.5–1.8), nor long-duration parenteral antibiotic therapy (HR 1.0, 95% CI 0.9–1.1) prevented failures. Our results might indicate the feasibility of a more practical approach to ischemic DFIs in terms of timing of vascularization and more oral antibiotic use. MDPI 2023-03-31 /pmc/articles/PMC10135376/ /pubmed/37107047 http://dx.doi.org/10.3390/antibiotics12040685 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Altmann, Dominique Waibel, Felix W. A. Forgo, Gabor Grigorean, Alexandru Lipsky, Benjamin A. Uçkay, Ilker Schöni, Madlaina Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title | Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title_full | Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title_fullStr | Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title_full_unstemmed | Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title_short | Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections |
title_sort | timing of revascularization and parenteral antibiotic treatment associated with therapeutic failures in ischemic diabetic foot infections |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135376/ https://www.ncbi.nlm.nih.gov/pubmed/37107047 http://dx.doi.org/10.3390/antibiotics12040685 |
work_keys_str_mv | AT altmanndominique timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT waibelfelixwa timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT forgogabor timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT grigoreanalexandru timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT lipskybenjamina timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT uckayilker timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections AT schonimadlaina timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections |